Science & Technology
A Novel Anti-infective Therapy for Treating Periodontitis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43DE034614-01
Award Ceiling
$309K
Award Floor
$309K
Close Date
Jul 31, 2027
503 days leftTotal Funding
$309K
Expected Awards
1
Posted Date
Aug 8, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R43DE034614-01
Description
SBIR Phase Phase I award: "A Novel Anti-infective Therapy for Treating Periodontitis" awarded to VIRTICI LLC in SEATTLE, Washington. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $309,038. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.